Cargando…

metabolic profiling of Parkinson's disease and mild cognitive impairment

Background: Early diagnosis of Parkinson's disease and mild cognitive impairment is important to enable prompt treatment and improve patient welfare, yet no standard diagnostic test is available. Metabolomics is a powerful tool used to elucidate disease mechanisms and identify potential biomark...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burté, Florence, Houghton, David, Lowes, Hannah, Pyle, Angela, Nesbitt, Sarah, Yarnall, Alison, Yu‐Wai‐Man, Patrick, Burn, David J., Santibanez‐Koref, Mauro, Hudson, Gavin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485028/ https://www.ncbi.nlm.nih.gov/pubmed/28394042 http://dx.doi.org/10.1002/mds.26992

Ejemplares similares

Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment
por: Lowes, Hannah, et al.
Publicado: (2020)

Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease
por: Pyle, Angela, et al.
Publicado: (2016)

Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson’s disease
por: Carbutt, Sophia, et al.
Publicado: (2015)

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)

Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
por: Lawson, Rachael A., et al.
Publicado: (2014)

Cell-free mitochondrial DNA in progressive multiple sclerosis
por: Lowes, Hannah, et al.
Publicado: (2019)

Extreme-Depth Re-sequencing of Mitochondrial DNA Finds No Evidence of Paternal Transmission in Humans
por: Pyle, Angela, et al.
Publicado: (2015)

Post-mortem ventricular cerebrospinal fluid cell-free-mtDNA in neurodegenerative disease
por: Lowes, Hannah, et al.
Publicado: (2020)

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease
por: Dissanayaka, Nadeeka N.W., et al.
Publicado: (2017)

Association of stroke and bleed events in non-valvular atrial fibrillation patients with direct oral anticoagulant prescriptions in NHS England between 2013 and 2016
por: Sheth, Harsh, et al.
Publicado: (2019)

Feasibility and impact of haplogroup matching for mitochondrial replacement treatment
por: Takeda, Yuko, et al.
Publicado: (2023)

Cognition and Gait Show a Selective Pattern of Association Dominated by Phenotype in Incident Parkinson’s Disease
por: Lord, Sue, et al.
Publicado: (2014)

Cognitive impairment in Parkinson's disease: impact on quality of life of carers
por: Lawson, RA, et al.
Publicado: (2016)

Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression
por: Cunnington, Michael S., et al.
Publicado: (2010)

Identifying delirium in Parkinson disease: A pilot study
por: Lawson, Rachael A., et al.
Publicado: (2020)

Assessing mitochondrial heteroplasmy using next generation sequencing: A note of caution
por: Santibanez-Koref, Mauro, et al.
Publicado: (2019)

Natural history of falls in an incident cohort of Parkinson’s disease: early evolution, risk and protective features
por: Lord, Sue, et al.
Publicado: (2017)

Factors Influencing Habitual Physical Activity in Parkinson’s Disease: Considering the Psychosocial State and Wellbeing of People with Parkinson’s and Their Carers
por: Mc Ardle, Ríona, et al.
Publicado: (2022)

Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease
por: Sleeman, Isobel, et al.
Publicado: (2019)

Accurate mitochondrial DNA sequencing using off-target reads provides a single test to identify pathogenic point mutations
por: Griffin, Helen R., et al.
Publicado: (2014)

The Role of Vitamin D in Disease Progression in Early Parkinson’s Disease
por: Sleeman, Isobel, et al.
Publicado: (2017)

Exome sequencing in undiagnosed inherited and sporadic ataxias
por: Pyle, Angela, et al.
Publicado: (2015)

Sebaceous tumours: a prototypical class of skin tumour for universal germline genetic testing
por: Gallon, R., et al.
Publicado: (2021)

How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies
por: Gallon, Richard, et al.
Publicado: (2021)

Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission
por: Arefi, Majid, et al.
Publicado: (2019)

Examining the Motor Phenotype of Patients with Both Essential Tremor and Parkinson's Disease
por: Simões, Rita M., et al.
Publicado: (2012)

Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology
por: Wilson, Joanna, et al.
Publicado: (2020)

Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease
por: Breen, David P., et al.
Publicado: (2016)

Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy
por: Yu-Wai-Man, Patrick, et al.
Publicado: (2017)

Human Chondrocytes Respond Discordantly to the Protein Encoded by the Osteoarthritis Susceptibility Gene GDF5
por: Ratnayake, Madhushika, et al.
Publicado: (2014)

Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson’s Disease
por: Morris, Rosie, et al.
Publicado: (2017)

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention
por: Lawson, Rachael A., et al.
Publicado: (2016)

Somatic mtDNA variation is an important component of Parkinson's disease
por: Coxhead, Jonathan, et al.
Publicado: (2016)

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?
por: Weil, Rimona S., et al.
Publicado: (2018)

Donepezil for mild cognitive impairment in Parkinson’s disease
por: Baik, Kyoungwon, et al.
Publicado: (2021)

Abnormal retinal thickening is a common feature among patients with ARSACS-related phenotypes
por: Yu-Wai-Man, Patrick, et al.
Publicado: (2014)

The Alzheimer’s disease metabolic brain pattern in mild cognitive impairment
por: Meles, Sanne K, et al.
Publicado: (2017)

Functional Characterization of the Osteoarthritis Susceptibility Mapping to CHST11—A Bioinformatics and Molecular Study
por: Reynard, Louise N., et al.
Publicado: (2016)

Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson’s Disease in the ICICLE-PD Cohort
por: Lawson, Rachael A., et al.
Publicado: (2021)

When ‘mild’ COVID-19 is not so mild
por: Minton, Kirsty
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8pbcm319gm7u32kkms4lq4n86r